Cargando…

Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression

Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Amato, Felice, Tomaiuolo, Rossella, Nici, Fabrizia, Borbone, Nicola, Elce, Ausilia, Catalanotti, Bruno, D'Errico, Stefano, Morgillo, Carmine Marco, De Rosa, Giuseppe, Mayol, Laura, Piccialli, Gennaro, Oliviero, Giorgia, Castaldo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009323/
https://www.ncbi.nlm.nih.gov/pubmed/24829907
http://dx.doi.org/10.1155/2014/610718
_version_ 1782479751351369728
author Amato, Felice
Tomaiuolo, Rossella
Nici, Fabrizia
Borbone, Nicola
Elce, Ausilia
Catalanotti, Bruno
D'Errico, Stefano
Morgillo, Carmine Marco
De Rosa, Giuseppe
Mayol, Laura
Piccialli, Gennaro
Oliviero, Giorgia
Castaldo, Giuseppe
author_facet Amato, Felice
Tomaiuolo, Rossella
Nici, Fabrizia
Borbone, Nicola
Elce, Ausilia
Catalanotti, Bruno
D'Errico, Stefano
Morgillo, Carmine Marco
De Rosa, Giuseppe
Mayol, Laura
Piccialli, Gennaro
Oliviero, Giorgia
Castaldo, Giuseppe
author_sort Amato, Felice
collection PubMed
description Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA complementary to the seed region of miR-509-3p, one of the miRNAs involved in the posttranscriptional regulation of the CFTR disease-gene of Cystic Fibrosis, and bearing suitable functionalization at its N- and C-ends aimed at improving its resistance to nucleases and cellular uptake, is able to revert the expression of the luciferase gene containing the 3′UTR of the gene in A549 human lung cancer cells, in agreement with the MD results that pointed at the formation of a stable RNA/PNA heteroduplex notwithstanding the short sequence of the latter. The here reported results widen the interest towards the use of small PNAs as effective anti-miRNA agents.
format Online
Article
Text
id pubmed-4009323
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40093232014-05-14 Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression Amato, Felice Tomaiuolo, Rossella Nici, Fabrizia Borbone, Nicola Elce, Ausilia Catalanotti, Bruno D'Errico, Stefano Morgillo, Carmine Marco De Rosa, Giuseppe Mayol, Laura Piccialli, Gennaro Oliviero, Giorgia Castaldo, Giuseppe Biomed Res Int Research Article Computational techniques, and in particular molecular dynamics (MD) simulations, have been successfully used as a complementary technique to predict and analyse the structural behaviour of nucleic acids, including peptide nucleic acid- (PNA-) RNA hybrids. This study shows that a 7-base long PNA complementary to the seed region of miR-509-3p, one of the miRNAs involved in the posttranscriptional regulation of the CFTR disease-gene of Cystic Fibrosis, and bearing suitable functionalization at its N- and C-ends aimed at improving its resistance to nucleases and cellular uptake, is able to revert the expression of the luciferase gene containing the 3′UTR of the gene in A549 human lung cancer cells, in agreement with the MD results that pointed at the formation of a stable RNA/PNA heteroduplex notwithstanding the short sequence of the latter. The here reported results widen the interest towards the use of small PNAs as effective anti-miRNA agents. Hindawi Publishing Corporation 2014 2014-04-15 /pmc/articles/PMC4009323/ /pubmed/24829907 http://dx.doi.org/10.1155/2014/610718 Text en Copyright © 2014 Felice Amato et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Amato, Felice
Tomaiuolo, Rossella
Nici, Fabrizia
Borbone, Nicola
Elce, Ausilia
Catalanotti, Bruno
D'Errico, Stefano
Morgillo, Carmine Marco
De Rosa, Giuseppe
Mayol, Laura
Piccialli, Gennaro
Oliviero, Giorgia
Castaldo, Giuseppe
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title_full Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title_fullStr Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title_full_unstemmed Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title_short Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression
title_sort exploitation of a very small peptide nucleic acid as a new inhibitor of mir-509-3p involved in the regulation of cystic fibrosis disease-gene expression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009323/
https://www.ncbi.nlm.nih.gov/pubmed/24829907
http://dx.doi.org/10.1155/2014/610718
work_keys_str_mv AT amatofelice exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT tomaiuolorossella exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT nicifabrizia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT borbonenicola exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT elceausilia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT catalanottibruno exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT derricostefano exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT morgillocarminemarco exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT derosagiuseppe exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT mayollaura exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT piccialligennaro exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT olivierogiorgia exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression
AT castaldogiuseppe exploitationofaverysmallpeptidenucleicacidasanewinhibitorofmir5093pinvolvedintheregulationofcysticfibrosisdiseasegeneexpression